ACTIVL ARTIFICIAL DISC

Prosthesis, Intervertebral Disc

FDA Premarket Approval P120024

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the activl® artificial disc. This device is indicated for reconstruction of the disc at one level (l4-l5 or l5-s1) following single-level discectomy in skeletally mature patients with symptomatic degenerative disc disease (ddd) with no more than grade i spondylolisthesis at the involved level. Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history, physical examination, and radiographic studies. The activl® artificial disc is implanted using an anterior retroperitoneal approach. Patients receiving the activl® artificial disc should have failed at least six months of nonoperative treatment prior to implantation of the device.

DeviceACTIVL ARTIFICIAL DISC
Classification NameProsthesis, Intervertebral Disc
Generic NameProsthesis, Intervertebral Disc
ApplicantAESCULAP IMPLANT SYSTEMS, LLC
Date Received2012-12-18
Decision Date2015-06-11
Notice Date2015-07-17
PMAP120024
SupplementS
Product CodeMJO
Docket Number15M-2218
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product No
Applicant Address AESCULAP IMPLANT SYSTEMS, LLC 3773 Corporate Parkway center Valley, PA 18034
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P120024Original Filing
S012 2022-06-13 30-day Notice
S011 2019-12-06 Normal 180 Day Track No User Fee
S010
S009
S008 2019-03-29 Real-time Process
S007 2017-11-06 135 Review Track For 30-day Notice
S006
S005 2017-02-24 Normal 180 Day Track No User Fee
S004 2016-12-23 Normal 180 Day Track
S003 2015-11-18 Normal 180 Day Track No User Fee
S002 2015-08-07 Real-time Process
S001 2015-07-24 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.